Found 2 results
AI as Tool vs AI as Inventor: Why the Distinction Will Decide the Next Decade of Patents
There are two versions of "AI in drug discovery" being marketed right now, and they are not the same thing. The distinction will decide the next decade of patents.
PRISMA 2020 in Practice: Five Things Most Systematic Reviews Still Get Wrong
PRISMA 2020 has been the reference reporting standard for systematic reviews for several years. Most journals require it; most reviewers check the checklist. Yet a striking proportion of published reviews still fall short.